Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 92,782 | 60,594 | 28,181 | 25,983 | 33,863 |
| Cost of Goods | 39,332 | 37,192 | 21,762 | 25,043 | 20,829 |
| Gross Profit | 53,450 | 23,402 | 6,419 | 940 | 13,034 |
| Operating Expenses | 82,916 | 86,448 | 84,724 | 95,321 | 123,619 |
| Operating Income | -29,134 | -62,854 | -77,543 | -94,338 | -109,756 |
| Interest Expense | 2,926 | 2,828 | 2,478 | 274 | 287 |
| Other Income | 364 | -478 | 728 | 147 | 655 |
| Pre-tax Income | -31,696 | -66,160 | -79,293 | -94,465 | -109,388 |
| Net Income Continuous | -31,696 | -66,160 | -79,293 | -94,465 | -109,388 |
| Net Income | $-31,696 | $-66,160 | $-79,293 | $-94,465 | $-109,388 |
| EPS Basic Total Ops | -0.42 | -0.94 | -1.26 | -1.69 | -2.03 |
| EPS Basic Continuous Ops | -0.42 | -0.94 | -1.26 | -1.70 | -2.03 |
| EPS Diluted Total Ops | -0.42 | -0.94 | -1.26 | -1.69 | -2.03 |
| EPS Diluted Continuous Ops | -0.42 | -0.94 | -1.26 | -1.70 | -2.03 |
| EBITDA(a) | $-24,500 | $-57,840 | $-71,300 | $-87,689 | $-103,953 |